BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 17303485)

  • 1. A randomized trial on the clinical performance of Nova T380 and Gyne T380 Slimline copper IUDs.
    Haugan T; Skjeldestad FE; Halvorsen LE; Kahn H
    Contraception; 2007 Mar; 75(3):171-6. PubMed ID: 17303485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical performance of the Nova T380 intrauterine device in routine use by the UK Family Planning and Reproductive Health Research Network: 5-year report.
    Cox M; Tripp J; Blacksell S;
    J Fam Plann Reprod Health Care; 2002 Apr; 28(2):69-72. PubMed ID: 12396775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Nova-T 200 intrauterine contraceptive device: a 12 year study.
    Baeyertz JD; Hartfield VJ
    N Z Med J; 1997 May; 110(1043):169-71. PubMed ID: 9196502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experience with the Copper-7 and Copper-T intrauterine devices at Siriraj Hospital in Bangkok, Thailand.
    Koetsawang S; Srisupandit S; Bhiraleus P; Rachawat D; Kiriwat O; Jirochkul V; Mitra M; Thomas M
    J Med Assoc Thai; 1982 Jan; 65(1):12-7. PubMed ID: 6153035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The TCu380 IUD: initial international experimental results with the latest "T" family IUD].
    Elia D; Belaisch J
    Contracept Fertil Sex (Paris); 1985 Sep; 13(9):973-8. PubMed ID: 12267501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term reversible contraception. Twelve years of experience with the TCu380A and TCu220C.
    Contraception; 1997 Dec; 56(6):341-52. PubMed ID: 9494767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multicenter study of the clinical performance of the Ortho Gyne-T380 Slimline intrauterine device in routine use in general practice and family planning clinics. UK Family Planning Research Network.
    Adv Contracept; 1993 Mar; 9(1):59-64. PubMed ID: 8342455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term study of the safety of the Dalkon Shield and Gyne-T 200 intrauterine devices.
    Rioux JE; Cloutier D; Dupont P; Lamonde D
    CMAJ; 1986 Apr; 134(7):747-51. PubMed ID: 3948091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A three-year study of the copper-7 minigravigard intrauterine contraceptive device in nulliparous women.
    Srisupandit S
    J Med Assoc Thai; 1988 Jun; 71(6):294-7. PubMed ID: 3171448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrauterine devices: an effective alternative to oral hormonal contraception.
    Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The frameless copper IUD (GyneFix) and the TCu380A IUD: results of an 8-year multicenter randomized comparative trial.
    Meirik O; Rowe PJ; Peregoudov A; Piaggio G; Petzold M;
    Contraception; 2009 Aug; 80(2):133-41. PubMed ID: 19631788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Copper-silver T: The classic T resuscitated].
    Jarvela S; Allonen H
    Contracept Fertil Sex (Paris); 1986 Jan; 14(1):45-7. PubMed ID: 12341240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Reasons for removal of intrauterine devices among women in general practice].
    Kolding L; Majeed HG
    Ugeskr Laeger; 2013 Mar; 175(13):884-6. PubMed ID: 23582897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A reanalysis of the Cu-7 intrauterine contraceptive device clinical trial and the incidence of pelvic inflammatory disease: a paradigm for assessing intrauterine contraceptive device safety.
    Roy S; Azen C
    Am J Obstet Gynecol; 1994 Jun; 170(6):1606-13; discussion 1613-6. PubMed ID: 8203417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The clinical efficacy of the copper-containing intrauterine devices Nova T and Copper-T-200 Ag in a randomized study (author's transl)].
    Altmann G; Feichtinger W; Havelec L; Beck A
    Wien Klin Wochenschr; 1981 Sep; 93(17):556-8. PubMed ID: 7303702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The copper-7 intrauterine contraceptive device: 5-year evaluation.
    Sellors JW
    Can Med Assoc J; 1981 Oct; 125(7):717-20. PubMed ID: 7326653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical experience with intrauterine contraceptive devices (IUDs) inserted with and without tail.
    Batár I; Lampé LG; Allonen H
    Acta Chir Hung; 1988; 29(4):385-93. PubMed ID: 3239338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Nova-T and Copper-T 200 in a five year's clinical comparison].
    Nygren KG; Allonen H; Nielsen NC; Luukkainen T; Pyorala T
    Contracept Fertil Sex (Paris); 1983 Nov; 11(11):1179-84. PubMed ID: 12312701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Copper intrauterine device use by nulliparous women: review of side effects.
    Hubacher D
    Contraception; 2007 Jun; 75(6 Suppl):S8-11. PubMed ID: 17531622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrauterine devices.
    Mccarthy TG; Ratnam SS
    Contemp Rev Obstet Gynaecol; 1992 Oct; 4(4):215-22. PubMed ID: 12345158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.